SMEDI Co., Ltd.

Informe acción KOSE:A118000

Capitalización de mercado: ₩73.1b

SMEDI Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Soo-Kyung Kim

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Subdued Growth No Barrier To SMEDI Co., Ltd. (KRX:118000) With Shares Advancing 27%

Mar 07
Subdued Growth No Barrier To SMEDI Co., Ltd. (KRX:118000) With Shares Advancing 27%

There Are Some Holes In Wooridul Huebrain's (KRX:118000) Solid Earnings Release

Mar 22
There Are Some Holes In Wooridul Huebrain's (KRX:118000) Solid Earnings Release

What Type Of Returns Would Wooridul Huebrain's(KRX:118000) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Jan 31
What Type Of Returns Would Wooridul Huebrain's(KRX:118000) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Is Wooridul Huebrain (KRX:118000) Using Debt Sensibly?

Dec 25
Is Wooridul Huebrain (KRX:118000) Using Debt Sensibly?

CEO

Soo-Kyung Kim (74 yo)

no data

Permanencia

Ms. Soo-Kyung Kim serves as Chief Executive Officer of SMEDI Co., Ltd. (formerly known as THE MEDIPHARM CO.,Ltd.). Ms. Soo-Kyung Kim served as Co-Chief Executive Officer of Sudo Pharmaceutical Industry Co....